By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Inotek Pharmaceuticals Corporation 

100 Cummings Center
Suite 419E
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-232-9660 Fax: 978-232-8975


SEARCH JOBS


Industry
Pharmaceutical






Company News
Inotek (ITEK) Announces The Completion Of The Recruitment Phase Of MATrX-1, The First Phase 3 Clinical Trial Of Trabodenoson For Glaucoma 8/24/2016 9:39:19 AM
Inotek (ITEK) Appoints Patrick Machado, JD, To Board Of Directors 8/18/2016 10:49:02 AM
Inotek (ITEK) Reports Second Quarter 2016 Financial Results And Operational Highlights 8/10/2016 11:21:21 AM
Inotek (ITEK) Announces Pricing Of $50.0 Million Of 5.75% Convertible Senior Notes Due 2021 8/2/2016 11:48:06 AM
Inotek Pharmaceuticals Corporation (ITEK) Expands Intellectual Property Portfolio With Combination Patent 7/22/2016 9:04:48 AM
Inotek Pharmaceuticals Corporation (ITEK) Initiates Phase 2 Dose-ranging Trial Of A Fixed-Dose Combination Of Trabodenoson, A Novel Treatment For Glaucoma, And Latanoprost 7/13/2016 10:43:32 AM
Inotek Pharmaceuticals Corporation (ITEK) To Present At Upcoming Investor Conferences 7/8/2016 9:29:17 AM
Inotek Pharmaceuticals Corporation (ITEK) Announces Participation In Fireside Chat At JMP Securities 2016 Life Sciences Conference 6/16/2016 10:21:49 AM
Inotek Pharmaceuticals Corporation (ITEK) Reports First Quarter 2016 Financial Results and Operational Highlights 5/11/2016 10:51:28 AM
Inotek Pharmaceuticals Corporation (ITEK) Announces Poster Presentations On Trabodenoson At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/26/2016 12:02:05 PM
123456789
//-->